The visionary and innovative Pail Laboratories completed a strategic Alliance with the Hindu Laboratory CIPLA, the second most strongest and important on India, to distribute and commercialize six drugs on El Salvador and Honduras for Asthma treatment.
CIPLA is a prominent pharmaceutic Hindu company founded on 1935 by Khwaja Abdul Hamied, with its headquarters in Mumbai, India.
CIPLA has worldwide presence and is well known for it´s innovative technology. It was the first Laboratory in India to receive a FDA certification.
CIPLA, leader on respiratory treatment in India with more tan 70% of Market, has worldwide presence on over 180 countries, and now comes to El Salvador in a strategic Alliance with Pail laboratorios to distribute the following drugs: Seroflo 125 (Salmeterol y Propionato de Fluticasona), Seroflo 250 (Salmeterol y Propionato de Fluticasona), Flohale 125 ( Fluticasona Propionato,) Beclate 250 ( Beclometasona Dipropionato) Asthalin (Salbutamol) and Respihaler (Levosalbutamol).
According to the WHO (World Health Organization), currently 235 million people suffer asthma, which it is the most common chronic disease in children.
The arrival of CIPLA laboratorios in Alliance with Pail Laboratories provides not only a new and reachable option for patients with this sickness, but also the fact of having a pharmaceutic Company with well known prestige and quality with presence on our country, to provide the distribution and commercialization of medicines in El Salvador and Honduras.